O-4 Trifluridine/tipiracil (TAS-102) with or without bevacizumab in patients with pretreated metastatic esophago-gastric adenocarcinoma (mEGA): A Danish randomized trial (LonGas)

P. Pfeiffer, M. Yilmaz, M. Nordsmark, S. Möller, I. Elle, M. Ladekarl, S. Winther, C. Qvortrup, L. Baeksgaard

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
JournalAnnals of Oncology
Volume33
Issue numberSuppl. 4
Pages (from-to)S380
ISSN0923-7534
DOIs
Publication statusPublished - Jun 2022
EventESMO 24th World Congress on Gastrointestinal Cancer 2022 - CCIB - Centre de Convencions Internacional de Barcelona, Barcelona, Spain
Duration: 29 Jun 20222 Jul 2022
https://www.esmo.org/meetings/past-meetings/esmo-world-congress-on-gastrointestinal-cancer-2022

Conference

ConferenceESMO 24th World Congress on Gastrointestinal Cancer 2022
LocationCCIB - Centre de Convencions Internacional de Barcelona
Country/TerritorySpain
CityBarcelona
Period29/06/202202/07/2022
Internet address

Bibliographical note

Abstract No. O-4

Cite this